SMIN - ETF AI Analysis
Top Page
iShares MSCI India Small Cap ETF (SMIN)
Rating:59Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Laurus Labs and Sona BLW Precision Forgings, have shown strong year-to-date performance, helping support the fund’s returns.
Targeted India Small-Cap Exposure
The ETF offers focused access to Indian small-cap companies, giving investors a way to tap into the growth potential of smaller businesses in a single country.
Broad Spread Across Many Stocks
With each top holding making up only a small slice of the portfolio, the fund reduces the impact of any single company’s performance on overall results.
Negative Factors
High Expense Ratio
The fund’s relatively high annual fee means more of the investment return goes to costs instead of staying with investors.
Mixed Recent Performance
The ETF has seen weak year-to-date and one-month performance, showing that returns can be choppy over shorter periods.
Single-Country Concentration
Almost all assets are invested in India, so the fund is heavily exposed to economic and market risks specific to that country.
SMIN vs. SPDR S&P 500 ETF (SPY)
AUM746.96M
RegionAsia-Pacific
Expense Ratio0.74%
Beta0.67
IssueriShares
Inception DateFeb 08, 2012
Dividend Yield2%
Asset ClassEquity
Index TrackedMSCI India Small Cap
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume82,858
30 Day Avg. Volume99,064
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SMIN Summary
The iShares MSCI India Small Cap ETF (SMIN) is a fund that tracks the MSCI India Small Cap Index, giving you a basket of smaller Indian companies in one investment. It holds a wide mix of businesses across the Indian economy, including names like Glenmark Pharmaceuticals and Biocon. Someone might invest in SMIN to tap into the growth potential of India’s smaller, fast-growing firms and to diversify beyond large, well-known companies. However, small-cap stocks in a single country can be very volatile, so the ETF’s price can rise and fall sharply with the Indian market.
How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.
What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.
SMIN Top 10 Holdings
SMIN is riding a wave of strength from industrial and specialty names like APAR Industries, Laurus Labs, Sona BLW, and Navin Fluorine, which have been steadily rising and giving the fund much of its spark. Consumer-focused Radico Khaitan is also adding fuel with solid recent momentum. On the flip side, Max Financial Services has been lagging, acting as a small brake on performance, while Glenmark Pharmaceuticals looks more mixed. The ETF is broadly spread across India’s small-cap universe, with all holdings India-based, so investors are betting squarely on the country’s domestic growth story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Coforge Limited | 1.68% | $12.72M | ₹791.94B | 16.27% | 73 Outperform | |
| Max Financial Services Limited | 1.11% | $8.38M | ₹484.20B | -5.90% | 59 Neutral | |
| Embassy Office Parks REIT | 1.09% | $8.28M | ₹416.67B | 6.79% | 76 Outperform | |
| Sona BLW Precision Forgings Ltd. | 1.05% | $7.97M | ₹509.29B | 102.63% | 74 Outperform | |
| Glenmark Pharmaceuticals Limited | 0.98% | $7.45M | ₹689.19B | 20.95% | 53 Neutral | |
| Radico Khaitan Limited | 0.98% | $7.45M | ₹600.24B | 57.88% | 65 Neutral | |
| APAR Industries Limited | 0.89% | $6.74M | ₹745.71B | 112.65% | 74 Outperform | |
| KEI Industries Limited | 0.85% | $6.44M | ₹447.41B | 15.54% | 63 Neutral | |
| Navin Fluorine International Limited | 0.84% | $6.35M | ₹434.50B | 87.69% | 64 Neutral | |
| IPCA Laboratories Limited | 0.81% | $6.10M | ₹506.47B | 43.70% | 74 Outperform |
SMIN Technical Analysis
Negative
―
Price Trends
70.77
Negative
69.47
Negative
67.67
Positive
Market Momentum
-0.36
Positive
37.91
Neutral
45.33
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 70.83, equal to the 50-day MA of 70.77, and equal to the 200-day MA of 67.67, indicating a neutral trend. The MACD of -0.36 indicates Positive momentum. The RSI at 37.91 is Neutral, neither overbought nor oversold. The STOCH value of 45.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SMIN.
SMIN Peer Comparison
Comparison Results
Performance Comparison
SMIN
iShares MSCI India Small Cap ETF
69.07
-1.46
-2.07%
INDA
iShares MSCI India ETF
―
―
―
FLIN
Franklin FTSE India ETF
―
―
―
INDY
iShares India 50 ETF
―
―
―
GIND
Goldman Sachs India Equity ETF
―
―
―
NFTY
First Trust India NIFTY 50 Equal Weight ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents